• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

颌骨骨肉瘤

Osteosarcoma of the jaw.

作者信息

Clark J L, Unni K K, Dahlin D C, Devine K D

出版信息

Cancer. 1983 Jun 15;51(12):2311-6. doi: 10.1002/1097-0142(19830615)51:12<2311::aid-cncr2820511224>3.0.co;2-z.

DOI:10.1002/1097-0142(19830615)51:12<2311::aid-cncr2820511224>3.0.co;2-z
PMID:6573939
Abstract

The records of 66 patients with osteosarcoma of the jaw were reviewed. The ages of the 42 males and 24 females ranged from 12 to 79 years (mean, 34.2 years). Swelling and pain, the most frequent presenting complaints, were noted an average of three months before the patient was seen by a physician. Fifty-one percent of the lesions involved the maxilla and 49% involved the mandible. The most common sites of involvement were the body of the mandible and the alveolar ridge of the maxilla. Radiologically, most of the lesions in the maxilla were osteoblastic (50%), whereas most of those in the mandible were osteolytic (43%). Chondroblastic osteosarcoma was the most frequent histologic type (48%) and was associated with the best survival rate (47%). Treatment included radical and local surgery with radiotherapy, chemotherapy, or various combinations. The recurrence rate for all treatment modalities was 70%. Patients treated by initial radical surgery had the best survival (80%). Survival decreased to 27% with local surgery. Of the 43 (65%) patients who died, most died with uncontrolled local disease; only four patients had documented distant metastasis, which involved lung, cervical lymph nodes, spinal column, and brain.

摘要

回顾了66例颌骨骨肉瘤患者的病历。42例男性和24例女性的年龄范围为12至79岁(平均34.2岁)。肿胀和疼痛是最常见的就诊主诉,平均在患者就医前三个月出现。51%的病变累及上颌骨,49%累及下颌骨。最常见的受累部位是下颌骨体和上颌牙槽嵴。放射学上,上颌骨的大多数病变为成骨型(50%),而下颌骨的大多数病变为溶骨型(43%)。软骨母细胞性骨肉瘤是最常见的组织学类型(48%),且生存率最佳(47%)。治疗包括根治性和局部手术联合放疗、化疗或各种组合。所有治疗方式的复发率为70%。接受初始根治性手术治疗的患者生存率最佳(80%)。局部手术的生存率降至27%。在死亡的43例(65%)患者中,大多数死于局部疾病未得到控制;只有4例患者有记录的远处转移,累及肺、颈部淋巴结、脊柱和脑。

相似文献

1
Osteosarcoma of the jaw.颌骨骨肉瘤
Cancer. 1983 Jun 15;51(12):2311-6. doi: 10.1002/1097-0142(19830615)51:12<2311::aid-cncr2820511224>3.0.co;2-z.
2
[Osteosarcoma of the jaws. Apropos of 12 cases].[颌骨骨肉瘤。附12例报告]
Rev Stomatol Chir Maxillofac. 1998 Oct;99(3):138-42.
3
Radical surgical treatment in craniofacial osteosarcoma gives excellent survival. A retrospective cohort study of 14 patients.颅面部骨肉瘤的根治性手术治疗可带来极佳的生存率。一项针对14例患者的回顾性队列研究。
Eur J Cancer B Oral Oncol. 1994 Nov;30B(6):374-6. doi: 10.1016/0964-1955(94)90014-0.
4
Management of osteosarcoma of the maxilla and mandible.
Am J Surg. 1980 Oct;140(4):572-6. doi: 10.1016/0002-9610(80)90215-9.
5
Osteosarcoma of the jaw bones. Long-term follow up of 48 cases.颌骨骨肉瘤。48例长期随访
Int J Oral Maxillofac Surg. 1997 Jun;26(3):191-7. doi: 10.1016/s0901-5027(97)80818-1.
6
Osteosarcoma of the jaw bones.颌骨骨肉瘤
Br J Oral Maxillofac Surg. 1997 Oct;35(5):357-62. doi: 10.1016/s0266-4356(97)90410-1.
7
Osteosarcoma of the jaw. The Chaim Sheba Medical Center experience.颌骨骨肉瘤。哈伊姆·谢巴医疗中心的经验。
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001 Apr;91(4):445-51. doi: 10.1067/moe.2001.112330.
8
[Current treatment methods for osteosarcoma of the jaw bones].[颌骨骨肉瘤的当前治疗方法]
Acta Stomatol Belg. 1996 Dec;93(4):177-81.
9
Well-differentiated osteosarcoma of the jaw bones: a clinicopathologic study of 15 cases.颌骨高分化骨肉瘤:15 例临床病理研究。
Am J Surg Pathol. 2010 Nov;34(11):1647-55. doi: 10.1097/PAS.0b013e3181f7dac6.
10
Osteogenic sarcoma of the jaws: factors influencing prognosis.颌骨骨肉瘤:影响预后的因素
Int J Oral Maxillofac Surg. 1997 Jun;26(3):198-204. doi: 10.1016/s0901-5027(97)80819-3.

引用本文的文献

1
Establishing a Mandibular Osteosarcoma Model in SD Rats Using Tissue Block Transplantation.采用组织块移植法建立 SD 大鼠下颌骨骨肉瘤模型。
In Vivo. 2024 Nov-Dec;38(6):2665-2671. doi: 10.21873/invivo.13743.
2
Osteosarcoma of Mandible - A Case Report.下颌骨肉瘤——病例报告
Indian J Surg Oncol. 2024 Sep;15(3):495-498. doi: 10.1007/s13193-024-01933-x. Epub 2024 Apr 3.
3
Clinical and Pathological Features of Osteosarcomas of the Jaws: A Retrospective Study.颌骨骨肉瘤的临床与病理特征:一项回顾性研究
Clin Pract. 2024 May 23;14(3):965-979. doi: 10.3390/clinpract14030077.
4
Clinical significance of adjuvant therapy after radical surgery for primary osteosarcoma of the jaws.颌骨原发性骨肉瘤根治术后辅助治疗的临床意义。
Wien Klin Wochenschr. 2023 Sep;135(17-18):488-495. doi: 10.1007/s00508-023-02228-x. Epub 2023 Jun 12.
5
A Rare Case of Extraosseous Osteosarcoma (EOS) of Parotid Gland.腮腺骨外骨肉瘤(EOS)1例罕见病例。
Indian J Otolaryngol Head Neck Surg. 2023 Jun;75(2):1215-1220. doi: 10.1007/s12070-023-03497-8. Epub 2023 Jan 30.
6
Osteogenic Sarcoma of the Head and Neck: Is Chemotherapy Needed?头颈部成骨肉瘤:需要化疗吗?
Curr Treat Options Oncol. 2023 May;24(5):528-541. doi: 10.1007/s11864-023-01073-4. Epub 2023 Apr 5.
7
Chondroblastic Osteosarcoma of the Mandible in a Patient on Risedronate: A Rare Case of Neoadjuvant Chemotherapy Failure.一名正在服用利塞膦酸盐的患者发生下颌骨软骨母细胞性骨肉瘤:新辅助化疗失败的罕见病例
Cureus. 2021 Nov 26;13(11):e19929. doi: 10.7759/cureus.19929. eCollection 2021 Nov.
8
Osteosarcoma of the temporal bone occurring 40 years after radiotherapy: A technical case report presenting resection of intra- and extracranial lesions followed by a one-stage reconstruction.放疗40年后发生的颞骨骨肉瘤:1例技术病例报告,介绍了颅内和颅外病变切除及一期重建情况。
Surg Neurol Int. 2021 Apr 14;12:152. doi: 10.25259/SNI_857_2020. eCollection 2021.
9
Chondroblastic osteosarcoma-A case report and review of literature.软骨母细胞性骨肉瘤——病例报告及文献综述
Clin Case Rep. 2019 Sep 30;8(11):2097-2102. doi: 10.1002/ccr3.1761. eCollection 2020 Nov.
10
The Utility of MDM2 and CDK4 Immunohistochemistry and MDM2 FISH in Craniofacial Osteosarcoma.MDM2 和 CDK4 免疫组化和 MDM2 FISH 在颅面部骨肉瘤中的应用。
Head Neck Pathol. 2020 Dec;14(4):889-898. doi: 10.1007/s12105-020-01139-x. Epub 2020 Feb 5.